EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Eltrombopag Inhibits Metastasis in Breast Carcinoma by Targeting HuR Protein

Yao Chen, Rui Zhang, Liuqing Yang, Pei Zhang, Feiyun Wang, Guoqiang Lin, Jiange Zhang, Yuying Zhu

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24043164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Yao Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Research Center of Chiral Drugs, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medici…. Hauptthemen laut MEDLINE: Breast Neoplasms, ELAV-Like Protein 1. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Education Commission, Shanghai Municipal Health Commission/Shanghai Municipal Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eltrombopag is a small molecule TPO-R agonist that has been shown in our previous studies to inhibit tumor growth by targeting Human antigen R (HuR) protein. HuR protein not only regulates the mRNA stability of tumor growth-related genes, but it also regulates the mRNA stability of a variety of cancer metastasis-related genes, such as Snail, Cox-2, and Vegf-c. However, the role and mechanisms of eltrombopag in breast cancer metastasis have not been fully investigated. The purpose of this study was to investigate whether eltrombopag can inhibit breast cancer metastasis by targeting HuR. Our study first found that eltrombopag can destroy HuR-AU-rich element (ARE) complexes at the molecular level. Secondly, eltrombopag was found to suppress 4T1 cell migration and invasion and inhibit macrophage-mediated lymphangiogenesis at the cellular level. In addition, eltrombopag exerted inhibitory effects on lung and lymph node metastasis in animal tumor metastasis models. Finally, it was verified that eltrombopag inhibited the expressions of Snail, Cox-2, and Vegf-c in 4T1 cells and Vegf-c in RAW264.7 cells by targeting HuR. In conclusion, eltrombopag displayed antimetastatic activity in breast cancer in an HuR dependent manner, which may provide a novel application for eltrombopag, hinting at the multiple effects of HuR inhibitors in cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsELAV-Like Protein 1AnimalsFemaleHumansCell Line, TumorCyclooxygenase 2Vascular Endothelial Growth Factor CBenzoatesHydrazinesPyrazoles

Stichwörter der Autor:innen

HuRbreast cancereltrombopag (ELB)lung metastasislymph node metastasismacrophage

Substanzen

Cyclooxygenase 2ELAV-Like Protein 1Vascular Endothelial Growth Factor CeltrombopagBenzoatesHydrazinesPyrazolesELAVL1 protein, human

Autor:innen und Institutionen

  • The Research Center of Chiral Drugs, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Shanghai Frontiers Science Center for Traditional Chinese Medicine Chemical Biology, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, C…
  • Shanghai Institute of Traditional Chinese Medicine, Shanghai 201203, China.

Förderung

  • National Natural Science Foundation of China
  • Shanghai Municipal Education Commission
  • Shanghai Municipal Health Commission/Shanghai Municipal Administration of Traditional Chinese Medicine
  • Shanghai Science and Technology Development Fund from Central Leading Local Government
  • Science and Technology Commission of Shanghai Municipality
  • "Chenguang Program" supported by Shanghai Education Development Foundation and Shanghai Municipal Education Commission
  • Open Project of National Major Scientific and Technological Infrastructure for Translational Medicine (Shanghai)
  • Open Project of Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs

Zitieren

APA

Chen, Y., Zhang, R., Yang, L., Zhang, P., Wang, F., Lin, G., Zhang, J., & Zhu, Y. (2023). Eltrombopag Inhibits Metastasis in Breast Carcinoma by Targeting HuR Protein. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043164

Vancouver

Chen Y, Zhang R, Yang L, Zhang P, Wang F, Lin G, et al. Eltrombopag Inhibits Metastasis in Breast Carcinoma by Targeting HuR Protein. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043164

BibTeX
@article{Chen2023,
  author = {Chen, Yao and Zhang, Rui and Yang, Liuqing and Zhang, Pei and Wang, Feiyun and Lin, Guoqiang and Zhang, Jiange and Zhu, Yuying},
  title = {Eltrombopag Inhibits Metastasis in Breast Carcinoma by Targeting HuR Protein},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24043164}
}
Kostenlos starten →